Discordant tuberculin skin and interferon-gamma tests during contact investigations: A dilemma for tuberculosis controllers

International Journal of Tuberculosis and Lung Disease

Volumn 13, Issue 5, 2009, Pages 662-664

  O'Neal, S ^a,b   Hedberg, K ^b   Markum, A ^c   Schafer, S ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON PUBLIC HEALTH DIVISION   (United States)

^c Klamath County Health Department   (United States)

Author keywords

Contact investigation; Epidemiology; Interferon gamma assay; Tuberculosis

Indexed keywords

GAMMA INTERFERON; GOLD;

ADULT; ARTICLE; BCG VACCINATION; BIOCHEMICAL EQUIPMENT; DIAGNOSTIC VALUE; DISEASE SURVEILLANCE; FEMALE; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL HAZARD; PREVALENCE; PRIORITY JOURNAL; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; BIOLOGICAL MARKERS; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; HUMANS; INCIDENCE; INFECTION CONTROL; INTERFERON-GAMMA; MALE; OREGON; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TUBERCULIN TEST; TUBERCULOSIS;

EID: 67649562853     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Centers for Disease Control and Prevention. Guidelines for using the QuantiFERON® Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR 2005; 54 (No. RR-15): 49-56.
2. Canadian Tuberculosis Committee (CTC). An Advisory Committee Statement (ACS). Updated recommendations on interferongamma release assays for latent tuberculosis infection. Can Comm Dis Report 2008; 34: 1-13.
3. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole blood IFN-γ assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med 2008; 177: 1164-1170.
4. Arend S M, Thijsen S F, Leyten E M, et al. Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med 2007; 175: 618-627.
5. Mahomed H, Hughes E J, Hawkridge T, et al. Comparison of Mantoux skin test with three generations of a whole blood IFN-gamma assay for tuberculosis infection. Int J Tuberc Lung Dis 2006; 10: 310-316.
6. Pai M, Gokhale K, Joshi R, et al. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood, interferon-γ assay with tuberculin skin testing. JAMA 2005; 293: 2746-2755.
7. Pollock N R, Campos-Nieto A, Kashino S, et al. Discordant QuantiFERON-TB Gold test results among us health care workers with increased risk of latent tuberculosis infection: a problem or solution? Infect Control Hosp Epidemiol 2008; 29: 878-886.
8. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146: 340-354.
9. Bennett D E, Courval J M, Onorato I, et al. Prevalence of tuberculosis infection in the United States population: the National Health and Nutrition Examination Survey, 1999-2000. Am J Respir Crit Care Med 2008; 177: 348-355.
10. Hennekens C, Buring J. Screening. In: Epidemiology in medicine. Boston, MA, USA: Little, Brown and Company, 1987: pp 337-338.